QURE uniQure N.V.

NEUTRAL Impact: 2/10 144
Horizon days Filed Jun 3, 2026 Processed 3d 2h ago SEC 0001973379-26-000219
Form 144 — notice of proposed sale of securities
Latest settled — T+1d
QURE ▼ -6.33% at T+1d
NEUTRAL call ✗ call lost -6.33% · α vs SPY -6.72% · entry $29.88 → $27.99
Next anchor: T+5d in 4d
Currently $26.45 · -11.48% from $29.88 entry
Entry anchored
Jun 3, 03:58 PM ET
via Databento tick
T+1d
-6.33%
call -6.33% · α -6.72%
$27.99
settled 2d ago
T+5d
call — · α —
in 4d
T+20d
call — · α —
in 26d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Director Jack Kaye filed a Form 144 notice of intent to sell 2,645 ordinary shares of uniQure N.V., valued at approximately $79,384, on June 3, 2026. The sale is pursuant to a Rule 10b5-1 trading plan and follows a stock option exercise. The small size relative to the company's $1.7B market cap makes this a routine insider transaction with minimal market impact.

Actionable Insight

This is a routine, pre-planned insider sale under a 10b5-1 plan by a director. The small dollar amount and plan adoption date over a year ago indicate no material non-public information concern. No action warranted.

Key Facts

  • Director Jack Kaye filed Form 144 to sell 2,645 ordinary shares.
  • Estimated aggregate value of the proposed sale is $79,384.
  • Sale is executed pursuant to a Rule 10b5-1 trading plan adopted on June 16, 2025.
  • Transaction follows a stock option exercise and is for cash.
  • The sale represents approximately 0.0004% of the company's $1.7B market cap.

Financial Impact

Proposed sale of 2,645 shares valued at $79,384, representing a negligible fraction of market cap.

dilution

Risk Factors

  • Insider selling pattern could escalate if additional directors or officers file similar notices.
  • Form 144 is only an intent to sell; the actual sale may not occur.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000219
Document: 0001973379-26-000219-index.html0001973379-26-000219
Document: 0001973379-26-000219.txt0001973379-26-000219
10 reports for QURE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for QURE — sortable, filterable
Type Now
Jun 3, 2026
3d ago
144
NEUTRAL ★ 2/10
$29.88 $27.99▼ −6.33%▼ −6.72%$26.45 (−11.48%)
May 5, 2026
4w ago
8-K
MIXED ★ 6/10
$21.16 $22.82▲ +7.84%▲ +6.46%$26.45 (+25.00%)
May 5, 2026
4w ago
Press Release
BEARISH ★ 6/10
$21.16 $22.82▼ −7.84%▼ −6.46%$26.45 (−25.00%)
Apr 27, 2026
5w ago
DEFA14A
NEUTRAL ★ 3/10
$17.90 $18.05▲ +0.84%▲ +1.32%$26.45 (+47.77%)
Mar 2, 2026
13w ago
Press Release
MIXED ★ 6/10
$10.50 $9.03▼ −14.00%▼ −13.09%$26.45 (+151.90%)
Mar 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$10.50 $9.03▼ −14.00%▼ −13.09%$26.45 (+151.90%)
Mar 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$10.50 $9.03▼ −14.00%▼ −13.09%$26.45 (+151.90%)
Mar 2, 2026
13w ago
Insider Cluster
BEARISH ★ 7/10
$10.50 $9.03▲ +14.00%▲ +13.09%$26.45 (−151.90%)
Feb 25, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.87 $17.12▼ −31.18%▼ −30.64%$26.45 (+6.35%)
Feb 25, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.87 $17.12▼ −31.18%▼ −30.64%$26.45 (+6.35%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (14h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access